developed a dedicated, central source of information to help medical leaders
and decision makers navigate through the current challenge on Australasia’s
This section will be regularly updated when new information becomes available.
RACMA is encouraging all members and non-members to email any queries or useful resources to the College at email@example.com.
- Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – The Journal of the American Medical Association (JAMA) Internal Medicine Kristina L. Bajema, MD, MSc; Ryan E. Wiegand, MS; Kendra Cuffe, MPH; Sadhna V. Patel, MPH; Ronaldo Iachan, PhD; Travis Lim, DrPH; Adam Lee, MS; Davia Moyse, MA; Fiona P. Havers, MD, MHS; Lee Harding, MS; Alicia M. Fry, MD, MPH; Aron J. Hall, DVM, MSPH; Kelly Martin, MPH; Marjorie Biel, MPH; Yangyang Deng, MS; William A. Meyer III, PhD; Mohit Mathur,MD, PhD; Tonja Kyle, MS; Adi V. Gundlapalli, MD, PhD; Natalie J. Thornburg, PhD; Lyle R. Petersen, MD, MPH; Chris Edens, PhD
- Antibodies, Immunity, and COVID-19 – The Journal of the American Medical Association (JAMA) Internal Medicine Brad Spellberg, MD; Travis B. Nielsen, PhD; Arturo Casadevall, MD, PhD